Baltimore, MD – June 24, 2018 – GE Healthcare showcased new molecular imaging and software solutions at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2018 that will help deliver the vision of precision health, giving personalized, quantitative data to clinicians. The company highlighted a new configuration for Discovery MI, the highest sensitivity digital... Read more
Agreement to focus on accelerating campus innovation from lab to real world via UCI Applied Innovation IRVINE, Calif. — (June 21, 2018) — Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, has embarked on a strategic collaboration with the University of California, Irvine – one of the first targeted academic partnerships the company envisions... Read more
20 JUN 2018 | DARMSTADT, GERMANY Partnership with Alibaba Health Investment in OLED Technology Center China Cooperation with Tongji University Anniversary celebration in Shanghai with key stakeholders Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced today announced moves designed to pave the way for an even more successful future in China. During the... Read more
New Thermo Scientific B R A H M S KRYPTOR GOLD Analyzer Instrument Combines Higher Throughput and Maximum Autonomy New KRYPTOR GOLD instrument features the precision and productivity required for clinical specialty diagnostics laboratories and patient diagnosis and prognosis research HENNIGSDORF, Germany, June 20, 2018 /PRNewswire/ — Scientists working in clinical and research laboratories now have... Read more
BREA, Calif., June 19, 2018 /PRNewswire/ — Beckman Coulter announced today the positive results of a clinical trial suggesting that blood tests may offer key benefits in the initial screening for obstructive sleep apnea. The study, which involved 264 male adult patients from six institutions, revealed that screening for changes in three specific biomarkers may be... Read more
Basel, 19 June 2018 Roche and Foundation Medicine reach definitive merger agreement to accelerate broad availability of comprehensive genomic profiling in oncology Together, the companies will leverage expertise in genomics and molecular information to enhance the development of personalised medicines and care for patients with cancer Merger focuses on driving ubiquity of Foundation Medicine’s high... Read more
Basel, 19 June 2018 Roche and Foundation Medicine reach definitive merger agreement to accelerate broad availability of comprehensive genomic profiling in oncology Together, the companies will leverage expertise in genomics and molecular information to enhance the development of personalised medicines and care for patients with cancer Merger focuses on driving ubiquity of Foundation Medicine’s high... Read more
Testing Performed Together with EUROPattern System Can Help Accelerate Lupus Diagnosis WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its EUROIMMUN Crithidia luciliae immunofluorescence test (CLIFT) and CLIFT sensitive assays have received FDA 510(k) clearance. CLIFT testing is critical in supporting the detection of anti-double stranded... Read more
PARIS, June 18, 2018 /PRNewswire/ — At the International Society of Magnetic Resonance in Medicine Conference (www.ismrm.org), Bruker announced the launch of the next version of its preclinical imaging software, ParaVision 360. It is the most advanced research-grade software for preclinical MRI, and has now also been extended to nuclear molecular imaging. ParaVision 360 enables sequential... Read more
PARIS, June 18, 2018 /PRNewswire/ — At the International Society of Magnetic Resonance in Medicine Conference (www.ismrm.org), Bruker announced the launch of the next version of its preclinical imaging software, ParaVision 360. It is the most advanced research-grade software for preclinical MRI, and has now also been extended to nuclear molecular imaging. ParaVision 360 enables sequential... Read more